-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
TScan Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to Q3 2025.
- TScan Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2025 was -1.77K %, a 38.3% decline year-over-year.
- TScan Therapeutics, Inc. annual Operating Margin for 2024 was -4.79K %, a 978% decline from 2023.
- TScan Therapeutics, Inc. annual Operating Margin for 2023 was -444 %, a 9.82% increase from 2022.
- TScan Therapeutics, Inc. annual Operating Margin for 2022 was -492 %, a 2.64% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)